Company
IndiaPublic company, NYSE: RDYDr Reddy's Laboratories Limited (NYSE: RDY), Bachupally, India – FDA Inspections
Inspection records and compliance data for Dr Reddy's Laboratories Limited in Bachupally. 3 FDA inspections on record, last inspected September 20, 2024. Publicly traded as NYSE: RDY.
Company Profile
This profile covers Dr Reddy's Laboratories Limited based in Bachupally, India.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected April 29, 2015. Last inspected September 20, 2024.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 20, 2024 | NAI | Human Drugs · Bioresearch Monitoring | 1252158 |
| February 27, 2020 | NAI | Human Drugs · Drug Quality Assurance | 1122501 |
| April 29, 2015 | NAI | Human Drugs · Drug Quality Assurance | 928806 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
AnaZeal Analyticals & Research Pvt Ltd
Invitron Advanced Analytics Private Limited
Eurofins Biopharma Product Testing India Private Ltd.
Patheon API Manufacturing Inc
ARL Biopharma, Inc.
Davion Inc
Microbiological Consultants, Inc.
Eurofins Analytical Science Laboratories, Inc
CMIC Pharma Science Co., Ltd.
Gram Laboratories Inc
Company Information
Name
Dr Reddy's Laboratories Limited
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3009483004
Address
45 46 - 54 Survey Nos 42, Innovation Plaza, Bachupally, India
Country
India
ID: b8bf1054-aff5-4e43-8319-48f33c09d531